WO2017220049A2 - Formulation pour le traitement des brûlures mictionnelles - Google Patents

Formulation pour le traitement des brûlures mictionnelles Download PDF

Info

Publication number
WO2017220049A2
WO2017220049A2 PCT/CN2017/097786 CN2017097786W WO2017220049A2 WO 2017220049 A2 WO2017220049 A2 WO 2017220049A2 CN 2017097786 W CN2017097786 W CN 2017097786W WO 2017220049 A2 WO2017220049 A2 WO 2017220049A2
Authority
WO
WIPO (PCT)
Prior art keywords
grams
formulation
follows
tea
measured
Prior art date
Application number
PCT/CN2017/097786
Other languages
English (en)
Chinese (zh)
Other versions
WO2017220049A3 (fr
Inventor
崔坤峰
Original Assignee
赵吉永
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 赵吉永 filed Critical 赵吉永
Publication of WO2017220049A2 publication Critical patent/WO2017220049A2/fr
Publication of WO2017220049A3 publication Critical patent/WO2017220049A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/62—Nymphaeaceae (Water-lily family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739—Sanguisorba (burnet)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Definitions

  • the invention relates to a scald formula, in particular to a scald treatment formula, belonging to the technical field of traditional Chinese medicine formula.
  • Burns are often low-calorie burns, and low-calorie burns can be called low-temperature burns. It is caused by burns caused by prolonged skin contact with low-temperature objects above body temperature. Exposure to a temperature of 70 ° C for one minute, the skin may be burned; and when the skin contact temperature of nearly 60 ° C for more than five minutes, it may also cause burns, this kind of burn is called low temperature burn; Chinese patent application number 201410414883.0, A scald drug is disclosed, which is applied to a variety of valuable traditional Chinese medicines; its formula is well-matched; it is widely used; the natural active ingredient of the drug is applied to the injured skin, and the burn wound is finally repaired, regenerated, and healed, and the skin is not skinned and healed.
  • the invention proposes a treatment scald formula, which has low cost, good effect of treating scald, and follows the step-by-step treatment of traditional Chinese medicine, and can well treat the burned affected area.
  • the formulation component is measured in grams as follows: the formulation component is measured in grams as follows: 10 to 30 grams of jujube bark, clarified white grass ash clarified water 10 to 50 grams, tea ground 1 ⁇ 10 Ke, mint grass 1 ⁇ 10 grams, dog oil 1 ⁇ 10 grams, rhubarb 10 ⁇ 30 grams, mantle 10 ⁇ 30 grams, Gongju 10 ⁇ 50 grams, lotus leaves 5 ⁇ 30 grams, honey 5 ⁇ 30 grams, Pueraria 10 to 30 grams of powder, 5 to 20 grams of tea tree oil, 5 to 10 grams of egg white, 5 to 15 grams of snails, 5 to 10 grams of aloe, 1 to 10 grams of scallion.
  • the kudzu root powder and the brine are mixed in a 1:1 weight ratio.
  • the brine concentration is from 2 to 5%.
  • the formulation components are mixed and smashed and coated on the affected area by loofah.
  • the formulation component is measured in grams as follows: the formulation component is measured in grams as follows: 30 grams of jujube bark, 30 grams of clarified white ash clarified water, 5 grams of tea ground, and mint 5 Gram, dog oil 5g, rhubarb 30g, cellar 30g, Gongju 10g, lotus leaf 30g, honey 10g, Pueraria powder 15g, tea tree oil 10g, egg white 5g, snail 5g, aloe 5 Gram, 1 gram of scallion; it is generally used when the affected area is burned, can achieve the cool and refreshing of the affected area, and can anti-inflammatory, swelling, pain relief and itching of the affected area; promote cell regeneration, prevent bacterial and fungal growth, and achieve the effect of treating the symptoms.
  • the formulation component is measured in grams as follows: the formulation component is measured in grams as follows: 10 g of jujube bark, 10 g of clear white ash clarified water, 3 g of tea ground, and mint grass 1 1g, dog oil 1g, rhubarb 10g, cellar 10g, Gongju 10g, lotus leaf 10g, honey 5g, Pueraria powder 20g, tea tree oil 5g, egg white 10g, snail 15g, aloe 10 Gram, 5 grams of scallion, which is generally used in the final course of the affected area, which can carry out anti-inflammatory phlegm and promote cell regeneration.
  • the scald treatment formula of the invention can be administered by external application, the medicine is simple and the side effect is small; the treatment can be carried out step by step during the treatment; the treatment can achieve the cool and refreshing of the affected part. It can also reduce inflammation, relieve pain and relieve itching of the affected area; promote cell regeneration, prevent bacterial and fungal growth, and will not leave phlegm, and achieve the effect of treating the symptoms.
  • the formulation component is measured in grams as follows: the formulation component is in grams The measurement is as follows: 10 to 30 grams of jujube bark, 10 to 50 grams of clarified white ash clarified water, 1 to 10 grams of tea leaves, 1 to 10 grams of mint grass, 1 to 10 grams of dog oil, 10 to 30 grams of rhubarb, 10 to 30 grams of mantle, 10 to 50 grams of Gongju, 5 to 30 grams of lotus leaf, 5 to 30 grams of honey, 10 to 30 grams of Pueraria, 5 to 20 grams of tea tree oil, 5 to 10 grams of egg white, 5 to 10 grams of snail 15 grams, 5 to 10 grams of aloe vera, 1 to 10 grams of scallion.
  • the kudzu root powder and the brine are mixed in a 1:1 weight ratio; the salt water concentration is 2 to 5%; the formula component is mixed and smashed and then coated on the affected part by the loofah.
  • the formulation components are measured in grams as follows: the formulation components are measured in grams as follows: 30 grams of jujube bark, 30 grams of clear white ash clarified water, 5 grams of tea ground, 5 grams of mint grass, 5 grams of dog oil 30 grams of rhubarb, 30 grams of mantle, 10 grams of Gongju, 30 grams of lotus leaf, 10 grams of honey, 15 grams of Pueraria powder, 10 grams of tea tree oil, 5 grams of egg white, 5 grams of snail, 5 grams of aloe, 1 gram of scallion; It is generally used when the affected area is burnt, can achieve the cool and refreshing of the affected area, and can anti-inflammatory, swelling, pain relief and itching of the affected area; promote cell regeneration, prevent bacterial and fungal growth, and achieve the effect of treating the symptoms.
  • the formulation components are measured in grams as follows: the formulation components are measured in grams as follows: 10 grams of jujube bark, 10 grams of clarified white ash clarified water, 3 grams of tea ground, 1 gram of mint grass, 1 gram of dog oil 10 grams of rhubarb, 10 grams of earthworm, 10 grams of gerbera, 10 grams of lotus leaf, 5 grams of honey, 20 grams of puerarin, 5 grams of tea tree oil, 10 grams of egg white, 15 grams of snail, 10 grams of aloe vera, 5 grams of scallion, It is generally used in the final course of the affected area, which is capable of anti-inflammatory and promoting cell regeneration.
  • the scald treatment formula of the invention can be administered by external application, the medicine is simple and the side effect is small; the treatment can be carried out step by step during the treatment; the treatment can achieve the cool and refreshing of the affected part. It can also reduce inflammation, relieve pain and relieve itching of the affected area; promote cell regeneration, prevent bacterial and fungal growth, and will not leave phlegm, and achieve the effect of treating the symptoms.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Insects & Arthropods (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Animal Husbandry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une formulation pour le traitement des brûlures mictionnelles, ladite formulation comprenant les constituants suivants en grammes : de 10 à 30 grammes d'écorce de jujubier, de 10 à 50 grammes d'eau clarifiée de pennisetum centrasiaticum, de 1 à 10 grammes de poudre de feuilles de thé, de 1 à 10 grammes d'herba menthae, de 1 à 10 grammes d'huile de chien, de 10 à 30 grammes de rhubarbe, de 10 à 30 grammes de radix sanguisorbae, de 10 à 50 grammes de chrysanthème, de 5 à 30 grammes de feuilles de lotus, de 5 à 30 grammes de miel, de 10 à 30 grammes de poudre de radix puerariae, de 5 à 20 grammes d'huile de théier, de 5 à 10 grammes de blanc d'œuf, de 5 à 15 grammes d'escargot, de 5 à 10 grammes d'aloès, et de 1 à 10 grammes de bulbus allii fistulosi. La formulation pour le traitement des brûlures mictionnelles utilise des moyens d'application externes pour l'administration, est appliquée facilement, et a peu d'effets secondaires. Une cure de traitement progressive est utilisée. La formulation refroidit et rafraîchit la zone touchée pendant le traitement, effectue une réduction de l'inflammation, une réduction du gonflement, une atténuation de la douleur et une atténuation des démangeaisons sur la zone touchée, favorise la régénération cellulaire, empêche la croissance des bactéries et des champignons, ne laisse pas de cicatrices, et permet d'obtenir un effet de traitement des causes profondes.
PCT/CN2017/097786 2016-06-21 2017-08-17 Formulation pour le traitement des brûlures mictionnelles WO2017220049A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610452651.3A CN106138649A (zh) 2016-06-21 2016-06-21 一种治疗烫伤配方
CN201610452651.3 2016-06-21

Publications (2)

Publication Number Publication Date
WO2017220049A2 true WO2017220049A2 (fr) 2017-12-28
WO2017220049A3 WO2017220049A3 (fr) 2018-02-15

Family

ID=57353419

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/097786 WO2017220049A2 (fr) 2016-06-21 2017-08-17 Formulation pour le traitement des brûlures mictionnelles

Country Status (2)

Country Link
CN (1) CN106138649A (fr)
WO (1) WO2017220049A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106138649A (zh) * 2016-06-21 2016-11-23 崔坤峰 一种治疗烫伤配方
CN107929591A (zh) * 2017-12-13 2018-04-20 绵阳市吉富精密机械有限公司 一种用于烫伤消炎止痛的配方

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102973914A (zh) * 2012-11-22 2013-03-20 项孝泓 一种治疗烫伤的中药药膏及其配制方法
CN104127581A (zh) * 2014-07-11 2014-11-05 庞东剑 一种外敷治疗烧伤的中药配方及其制备方法
CN105055661A (zh) * 2015-07-17 2015-11-18 曾德锋 用于治疗烫伤的组合物及其制备方法
CN106138649A (zh) * 2016-06-21 2016-11-23 崔坤峰 一种治疗烫伤配方

Also Published As

Publication number Publication date
CN106138649A (zh) 2016-11-23
WO2017220049A3 (fr) 2018-02-15

Similar Documents

Publication Publication Date Title
US11571452B2 (en) Method of treating a skin wound with a liquid-state topical pharmaceutical composition
CN104857312A (zh) 一种防治伤口感染促进伤口愈合的中药组合物
CN101837082B (zh) 治疗烧伤的中药制剂
WO2017220049A2 (fr) Formulation pour le traitement des brûlures mictionnelles
CN104825941B (zh) 一种治疗脚气的中草药组合物及其制备方法
WO2017220048A2 (fr) Formulation pour le traitement des brûlures mictionnelles, la réduction de l'inflammation et le soulagement de la douleur
CN105535822A (zh) 治疗痔疮的中药组合物及其制备方法
CN110787104A (zh) 一种复方中药牙膏及其制备方法和应用
CN104940547B (zh) 一种治疗痔疮的外用中药组合物及其制备工艺
CN102846799A (zh) 烧烫伤中药外用膏及其制备方法
WO2018000727A1 (fr) Préparation pour le traitement de la dermatite dermatite de contact et son procédé de préparation
CN108114090B (zh) 一种治疗痔疮和烧烫伤的中药组合物
CN103127483B (zh) 一种治疗脉管炎的外敷药及其制备方法
CN106728069B (zh) 一种治疗烫烧伤的祛腐生肌膏
CN104800427A (zh) 一种烧烫伤康复敷剂及其制备方法
CN104510815B (zh) 防治肉猪皮炎的中药制剂
CN106798364A (zh) 一种冻疮防治手套衬布
CN103705615A (zh) 一种治疗烧烫伤的外敷中药散剂
CN108066466A (zh) 一种治疗烧烫伤的中药组合物及其制备方法与应用
CN107198763A (zh) 一种防治小腿静脉曲张的外用中药及其制备方法
CN101129459B (zh) 治疗烧烫伤的药物及其制备方法
CN105125926A (zh) 用于治疗烧烫伤的药粉及制备方法
CN105194156B (zh) 一种治疗烧烫伤的中药制剂
TW201429483A (zh) 治療刀傷、燒傷及多種創傷中藥組合物
CN104491334A (zh) 一种治疗痔疮术后疼痛的中药熏洗剂及护理方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17814786

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17814786

Country of ref document: EP

Kind code of ref document: A2